Natural ghrelin in advanced cancer patients with cachexia, a case series.

David BlumSusanne de Wolf-LinderRolf OberholzerMichael BrändleThomas HundsbergerFlorian Strasser

Published in: Journal of cachexia, sarcopenia and muscle (2021)

Ghrelin was safe in advanced patients with cancer cachexia without dose-limiting toxicity and well tolerated. The intervention was very complex, and the number of patients included was small. There was a positive effect on nutritional intake and patient narratives.

Keyphrases

advanced cancer
end stage renal disease
palliative care
newly diagnosed
randomized controlled trial
ejection fraction
chronic kidney disease
case report
peritoneal dialysis
oxidative stress
physical activity
weight gain